Print page

Focus on Pharma Podcast: Episode 3: Inside the FDA and the New Transparency Initiative

Accused of being too chummy with the drug industry, FDA has moved to improve transparency. CDER's Helen Winkle discusses the initiative's progress.

http://www.accelacomm.com/jaw/source/32/50881709/